Company profile page for Ovid therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information Financials. Die Ovid Therapeutics Inc Registered Shs Aktie wird unter der ISIN US6904691010 an den Börsen Frankfurt, München, Stuttgart, Berlin, NASDAQ, Bats, NDB, Lang & … quotes delayed at least 15 minutes, all others at least 20 minutes. News zur OVID THERAPEUTICS AKTIE und aktueller Realtime-Aktienkurs OVID-19 test sales boost Abbott in Street-beating Q4 Investors are selling off shares of the drugmaker following negative results from a … All rights reserved. About Ovid Therapeutics Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. 1125 N. Charles St, Baltimore, MD 21201. The stock has traded between $2.62 and $2.79 so far today. Ovid Therapeutics News: This is the News-site for the company Ovid Therapeutics on Markets Insider Dec 01, 2020 Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint. Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine® approach to develop medicines that transform the lives of patients with rare neurological disorders. 9 Wall Street analysts have issued ratings and price targets for Ovid Therapeutics in the last 12 months. OVID | Complete Ovid Therapeutics Inc. stock news by MarketWatch. News & Events. The company will decide what to do after getting the full results from the trial and concluding discussions with the  U.S. Food and Drug Administration. Presentations & Events. Get the latest Ovid Therapeutics Inc (OVID) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Ovid Therapeutics Inc. (NASDAQ:OVID)’s beta value is holding at 1.83, while the average true range (ATR) indicator is currently reading 0.26. Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. Get Ovid Therapeutics Inc (OVID:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of Angelman Syndrome Did Not Meet Primary Endpoint ; Ovid Therapeutics to Present at the American Epilepsy Society (AES) 2020 Virtual Congress Ovid Therapeutics Inc. (NASDAQ:OVID) went up by 3.13% from its latest closing price compared to the recent 1-year high of $9.40. Copyright West LLC. Binance Coin (BNB) Price Predictions: Where Will BNB Go After All-Time High? Ovid Therapeutics Inc. SEC filings breakout by MarketWatch. The company’s stock price has collected 2.33% of gains in the last five trading sessions. Ovid Therapeutics notes that the secondary endpoints of the study concerned “sleep, communication, motor function, socialization, daily living skills and behavior domains.” The final results for these aren’t in, but early results point toward no difference when compared to a placebo. ... Latest OVID News From Around the Web. Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicine ® approach to develop medicines that transform the lives of patients with rare neurological disorders. We are a biopharmaceutical company focused exclusively on developing impactful medicines for … Their average twelve-month price target is $12.57, predicting that the stock has a possible upside of 240.69%. Ovid has a broad pipeline of potential first-in-class medicines. Ovid Therapeutics Inc (OVID) stock has fallen -2.98% while the S&P 500 is up 2.15% as of 2:26 PM on Thursday, Nov 5. This website uses a variety of cookies, which … How has Ovid Therapeutics's share price performed over time and what events caused price changes? Ovid focuses on … 10 talking about this. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Ovid Therapeutics against related stocks people have also bought. (Add your “underperform” vote.) The company’s stock price has collected 3.69% of gains in the last five trading sessions. View real-time stock prices and stock quotes for a full financial overview. Ovid Therapeutics News: Why OVID Stock Is Plunging 55% Today. Ovid has a broad pipeline of potential first-in-class medicines in development. As of this writing, more than 8 million shares of OVID stock have changed hands. Minimum 15 minutes delayed. February 1, 2021. Copyright © The company was founded in 2014 and is based in New York City, New York. Ovid Therapeutics, a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States.